Skip to main content
Top
Published in: Clinical Neuroradiology 2/2023

01-06-2023 | Computed Tomography | Editorial

One Treatment to Heal them all: Thrombectomy also Benefits Stroke with Large Ischemic Core

Author: Götz Thomalla

Published in: Clinical Neuroradiology | Issue 2/2023

Login to get access

Excerpt

Thrombectomy has revolutionized stroke treatment worldwide, improving the outlook for severe stroke with a treatment success previously unheard of in acute stroke treatment. Following the Dutch MR CLEAN trial [1], a series of clinical trials has demonstrated the benefit of endovascular thrombectomy (EVT) for patients with large vessel occlusion. In the pooled HERMES analysis of the “first wave” of stroke thrombectomy trials, the number needed to treat with thrombectomy to reduce disability by at least 1 level on the modified Rankin scale (mRS) at 90 days for 1 patient was as low as 2.6 [2]; however, in most of these trials enrolment excluded patients with large ischemic core, either based on the visual assessment of pre-treatment Alberta Stroke Program Early CT score (ASPECTS) or by quantification of the ischemic core using perfusion CT. Moreover, in the early trials the majority of patients were treated within the first 6 h of known symptom onset. As a result, most international guidelines adopted the recommendation for treatment with thrombectomy for large vessel occlusion within the first 6 h guidelines for patients with no signs of extended infarction, usually operationalized by an ASPECTS of ≥ 6. It took no longer than another 2 years until two further groundbreaking trials of stroke thrombectomy were published that challenged the strict time window: both, DAWN and DEFUSE‑3 randomized patients in a late time window up to 16 or 24 h after known onset or those with unknown time of symptom onset to treatment with EVT or usual care, if patients had a perfusion mismatch (DEFUSE-3) [3], or a mismatch between a severe clinical deficit and only a small infarct core (DAWN) [4]. In these highly selected patients, the treatment effect of EVT was even stronger than in previous trials but again, and on purpose, patients with already large ischemic infarcts were excluded from both trials. Therefore, until recently, the main open question regarding thrombectomy for stroke remained whether EVT is effective or useless in patients with already extensive ischemic stroke lesions. This question is answered now. …
Literature
1.
go back to reference Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20.CrossRefPubMed Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20.CrossRefPubMed
2.
go back to reference Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31.CrossRefPubMed Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31.CrossRefPubMed
3.
go back to reference Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708–718. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708–718.
4.
go back to reference Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21.CrossRefPubMed Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21.CrossRefPubMed
5.
go back to reference Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large Ischemic region. N Engl J Med. 2022;386(14):1303–13.CrossRefPubMed Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large Ischemic region. N Engl J Med. 2022;386(14):1303–13.CrossRefPubMed
6.
go back to reference Schroder J, Thomalla G. A critical review of Alberta stroke program early CT score for evaluation of acute stroke imaging. Front Neurol. 2016;7:245.PubMed Schroder J, Thomalla G. A critical review of Alberta stroke program early CT score for evaluation of acute stroke imaging. Front Neurol. 2016;7:245.PubMed
7.
go back to reference Bendszus M, Bonekamp S, Berge E, et al. A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window. Int J Stroke. 2019;14(1):87–93.CrossRefPubMed Bendszus M, Bonekamp S, Berge E, et al. A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window. Int J Stroke. 2019;14(1):87–93.CrossRefPubMed
Metadata
Title
One Treatment to Heal them all: Thrombectomy also Benefits Stroke with Large Ischemic Core
Author
Götz Thomalla
Publication date
01-06-2023
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 2/2023
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-023-01304-z

Other articles of this Issue 2/2023

Clinical Neuroradiology 2/2023 Go to the issue